Health News Review
  • Oct 2 2014

    More conflicted, imbalanced prostate information from FOX News

    Conflicted and imbalanced because they let Dr. David Samadi, who runs a robotic surgery center in New York, be the unchallenged expert about “raising awareness for prostate cancer.”  In fact, they let the self-promotional Samadi get away with promoting the #SamadiChallenge – which, if you use that on Twitter, will eat up 16 of your [...]

    10 Comments
  • Jul 1 2014

    Conflict of interest: ABC allows Ob-Gyn/”journalist” to report her opinion on pelvic exam recommendations

    From MedPageToday: Average-risk, asymptomatic women do not benefit from pelvic exams as part of routine care and face potential harms from false-positive results, according to a new clinical guideline. When screening for cervical cancer, clinicians should limit the physical examination to visual inspection of the cervix and use of cervical swabs for cancer or human [...]

    17 Comments
  • Jun 11 2014

    GE’s “Let’s Talk Mammo” blames media, downplays false positives

    Viewing false positives and ensuing anxiety as a potential harm of mammography is often scoffed at by those who promote mammography at all costs.  With a different view on that topic, here is a guest post by Mary Guiden, a communications manager and writer at the University of Washington and a former journalist who blogs [...]

    1 Comment
  • Mar 10 2014

    Another conflicted journalism training event by the National Press Foundation

    On the Knight Science Journalism Tracker, Paul Raeburn writes, “Beware the National Press Foundation’s ‘Tips for High-Fidelity Science Reporting’ webinar.” The announcement by the National Press Foundation states: Any journalist who wants to improve her or his work on scientific topics will benefit from this webinar. It will highlight common challenges in communicating science and [...]

    2 Comments
  • Dec 10 2013

    Last week “clinical trial system broken”; this week “luxury journals distort/damage science”

    In the BMJ recently: “The clinical trial system is broken and it’s getting worse, according to longstanding Food and Drug Administration investigator, Thomas Marciniak. … “Drug companies have turned into marketing machines. They’ve kind of lost sight of the fact that they’re actually doing something which involves your health,” Marciniak says. “You’ve got to take [...]

    1 Comment
  • Dec 2 2013

    Coumadin, Clinton, and corporate conspired conformity: The case for decentralizing medical practice guidelines

    The following is a guest post submitted by David K. Cundiff, MD, who recently submitted a post that drew a great deal of interest on the site. ———————— Stroke, an American Heart Association/American Stroke Association (AHA/ASA) journal, recently published my systematic review of Anticoagulants for Cerebral Venous Thrombosis (CVT). However, the journal editor rightly classified [...]

    3 Comments
  • Nov 24 2013

    Statins and cardiovascular conflicts of interest

    I’d like to see a public survey of comprehension of the recent splash of news about new guidelines for heart disease prevention and statin drug use.  Heads must be spinning. Here are some of the pieces that I found noteworthy: In the BMJ, Jeanne Lenzer writes, “Majority of panelists on controversial new cholesterol guidelines have [...]

    16 Comments
  • Oct 8 2013

    Ethics problem: physician-journalists interview colleagues without disclosing conflict

    A physician wrote to me saying that the following story was “egregious because it is factually on another planet.” The story in question was  PBS Newshour “special correspondent” Dr. Emily Senay interviewing Dr. Claudia Henschke of Mount Sinai Hospital about lung cancer screening. In the interview, CT scan advocate Henschke played fast and loose with [...]

    2 Comments
  • Sep 18 2013

    Patient protection from conflicted medical guidelines

    A piece in the BMJ, “Ensuring the integrity of clinical practice guidelines: a tool for protecting patients,” lists: Red flags that should raise substantial skepticism among guideline readers (and medical journals) Sponsor(s) is a professional society that receives substantial industry funding; Sponsor is a proprietary company, or is undeclared or hidden Committee chair(s) have any [...]

    1 Comment
  • Jul 30 2013

    If you have low back pain, chances are increasing that you won’t be treated based on best evidence

    That’s the strong suggestion of a study published in JAMA Internal Medicine, “Worsening Trends in the Management and Treatment of Back Pain.” It concludes: “Despite numerous published national guidelines, management of routine back pain increasingly has relied on advanced diagnostic imaging, referrals to other physicians, and use of narcotics, with a concomitant decrease in (nonsteroidal [...]

    1 Comment